Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Retinoblastoma Gene01:20

The Retinoblastoma Gene

4.7K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.7K
Genetic Screens02:46

Genetic Screens

5.6K
Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing  genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
5.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A novel <i>CAPN5</i> missense variant associated with autosomal dominant neovascular inflammatory vitreoretinopathy.

Ophthalmic genetics·2026
Same author

In vivo elastography of the human retina using light-evoked intrinsic actuation.

bioRxiv : the preprint server for biology·2026
Same author

Optoretinography in R9AP-bradyopsia reveals the essential role of G-protein signaling in the human cone elongation response.

bioRxiv : the preprint server for biology·2026
Same author

Evaluating the Utility of Paired Tumor and Germline Targeted DNA Sequencing for Pediatric Oncology Patients: A Single Institution Report.

Pediatric blood & cancer·2026
Same author

Remarkable response to radiation in a non-enhancing diffuse pediatric-type high-grade glioma with germline <i>ATM</i> mutation: The role of PET imaging and integrated histological and molecular analysis.

Neuro-oncology advances·2026
Same author

Bi-allelic variants in FSD1L cause retinitis pigmentosa with or without neurological involvement.

American journal of human genetics·2026
Same journal

Home Tonometry and Perimetry: Addressing an Unmet Need in Glaucoma Care.

International ophthalmology clinics·2026
Same journal

Bleb Revision Techniques for Hypotony Maculopathy: A Review.

International ophthalmology clinics·2026
Same journal

Cyclodialysis Cleft Closure Following Suprachoroidal Spacer Implantation.

International ophthalmology clinics·2026
Same journal

Descemet Membrane Detachment During Ab-Interno Canaloplasty.

International ophthalmology clinics·2026
Same journal

Inflammatory Keratitis and IOP Spike After Repeat SLT in Pseudoexfoliation Glaucoma: Case Report and Literature Review.

International ophthalmology clinics·2026
Same journal

Beyond the Bottle: Lessons From the Laser in Glaucoma and Ocular Hypertension Trial.

International ophthalmology clinics·2026
See all related articles

Related Experiment Video

Updated: Jan 17, 2026

Reconstruct Human Retinoblastoma In Vitro
06:52

Reconstruct Human Retinoblastoma In Vitro

Published on: October 11, 2022

1.7K

Retinoblastoma: Advances in Genetic Testing.

Mark Lindquist1, Debarshi Mustafi1,2, Erin Crotty3

  • 1Department of Ophthalmology, University of Washington, Seattle, WA.

International Ophthalmology Clinics
|September 25, 2025
PubMed
Summary
This summary is machine-generated.

Genetic testing for the RB1 gene is essential for retinoblastoma diagnosis, treatment, and family risk assessment. Identifying germline mutations guides prognosis and informs family planning for heritable disease.

Keywords:
genetic testinglong-read sequencingretinoblastoma

More Related Videos

A Blood-based Test for the Detection of ROS1 and RET Fusion Transcripts from Circulating Ribonucleic Acid Using Digital Polymerase Chain Reaction
10:35

A Blood-based Test for the Detection of ROS1 and RET Fusion Transcripts from Circulating Ribonucleic Acid Using Digital Polymerase Chain Reaction

Published on: April 5, 2018

10.7K
Establishment and Propagation of Human Retinoblastoma Tumors in Immune Deficient Mice
07:55

Establishment and Propagation of Human Retinoblastoma Tumors in Immune Deficient Mice

Published on: August 4, 2011

12.2K

Related Experiment Videos

Last Updated: Jan 17, 2026

Reconstruct Human Retinoblastoma In Vitro
06:52

Reconstruct Human Retinoblastoma In Vitro

Published on: October 11, 2022

1.7K
A Blood-based Test for the Detection of ROS1 and RET Fusion Transcripts from Circulating Ribonucleic Acid Using Digital Polymerase Chain Reaction
10:35

A Blood-based Test for the Detection of ROS1 and RET Fusion Transcripts from Circulating Ribonucleic Acid Using Digital Polymerase Chain Reaction

Published on: April 5, 2018

10.7K
Establishment and Propagation of Human Retinoblastoma Tumors in Immune Deficient Mice
07:55

Establishment and Propagation of Human Retinoblastoma Tumors in Immune Deficient Mice

Published on: August 4, 2011

12.2K

Area of Science:

  • Oncology
  • Genetics
  • Ophthalmology

Background:

  • Retinoblastoma is a genetic cancer caused by RB1 gene mutations.
  • Genetic testing is vital for diagnosis, treatment, and surveillance.
  • Germline mutations impact heritability, prognosis, and family risk.

Purpose of the Study:

  • To highlight the importance of genetic testing in retinoblastoma management.
  • To outline recommended genetic testing strategies.
  • To discuss the potential of new technologies like long-read sequencing.

Main Methods:

  • Testing tumor tissue first, followed by peripheral blood DNA analysis for germline variants.
  • Targeted sequencing for at-risk family members.
  • Utilizing newer technologies like long-read sequencing for broader applications.

Main Results:

  • Germline mutations determine heritable retinoblastoma, influencing patient outcomes and family planning.
  • A clear testing pathway exists using tumor and blood samples.
  • Long-read sequencing offers scalability and new prognostic insights.

Conclusions:

  • Genetic testing is fundamental for personalized retinoblastoma care and family risk assessment.
  • Accessible genetic testing, including advanced technologies, can improve global patient outcomes.
  • Early identification of RB1 variants is crucial for effective management.